Sat, Nov 22, 2014, 10:58 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • bioimmunomabman bioimmunomabman Jul 9, 2013 10:29 AM Flag

    Options active

    Above average volume in the July 18 calls. Price started declining around the time of the trade. I can't tell if the trade was a buy, or sell, but based on the stock price reaction it appears to be a sale. Once again, IMGN can't hold above $18. It would help if the execs would stop selling shares every time the price increases. If Dan and Greg don't think IMGN has upside, they should move on. I think they have done enough damage, or failed to do anything useful for the shareholders. John Lambert (and team) are the only value creators at IMGN as far as I can see. This is getting old, just have to sell stock and calls above $18 I guess.

9.84+0.16(+1.65%)Nov 21 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
XOMA Corporation
NasdaqGMFri, Nov 21, 2014 4:00 PM EST
Hexcel Corp.
NYSEFri, Nov 21, 2014 4:02 PM EST